Bruce Sands, MD
Enriched profileDr. Burrill B. Crohn Professor of Medicine and Chief of the Dr. Henry D. Janowitz Division of Gastroenterology · Icahn School of Medicine at Mount Sinai
Bruce Sands is Dr. Burrill B. Crohn Professor of Medicine and Chief of the Dr. Henry D. Janowitz Division of Gastroenterology at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 1,173 publications with 67,663 citations (h-index 109); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Gastroenterology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Bruce Sands, MD, is Dr. Burrill B. Crohn Professor of Medicine and Chief of the Dr. Henry D. Janowitz Division of Gastroenterology at Icahn School of Medicine at Mount Sinai. The public record shows 1,173 publications with 67,663 citations (h-index 109), centered on Inflammatory Bowel Disease, Ocular Diseases and Behçet’s Syndrome, Rheumatoid Arthritis Research and Therapies. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 34 companies, 2 NIH-funded awards (2008–2023).
- Most recent indexed publication: 2026 · Inflammatory bowel diseases
- Top research focus: Inflammatory Bowel Disease
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 373.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Sponsor: Abivax S.A.
- Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes
Sponsor: Icahn School of Medicine at Mount Sinai
Industry payments
Updated 18 Oct 2026
34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202521 payments$30,150openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year202518 payments$28,033openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20254 payments$19,806openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
58%Aminosalicylate28%Mesalamine100%Part D<11 patientsRifamycin Antibacterial16%Xifaxan100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
42%Interleukin-12 Antagonist20%Stelara100%Part D<11 patientsJAK inhibitor11%Rinvoq100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
2 NIH research awards on record, funded 2008–2023 per NIH RePORTER. The latest:
- Bidirectional Brain-Gut Signaling in the Persistence of IBS-like Symptoms in Inflammatory Bowel Disease
University of California Los Angeles
FY2026$828,108R01DK147396 - Translating Scientific Evidence into Practice using Digital Medicine and Electronic Patient Reported Outcomes
Icahn School of Medicine at Mount Sinai
FY2023$1,192,712U01TR002997 - Translating Scientific Evidence into Practice using Digital Medicine and Electronic Patient Reported Outcomes
Icahn School of Medicine at Mount Sinai
FY2022$1,197,410U01TR002997
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.
Inflammatory bowel diseases
Clinical Trial2026 - IOIBD: the International Organization for the Study of Inflammatory Bowel Disease.
Therapeutic advances in gastroenterology
Review2026 - Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles.
Therapeutic advances in gastroenterology
Review2026 - Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.
Inflammatory bowel diseases
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisArticle3,909 citations2005
- 02Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisArticle2,892 citations2013
- 03
- 04Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseArticle2,756 citations1999
- 05Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseArticle2,720 citations2013
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/bruce-sands-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
en.wikipedia.org/wiki/Bruce_E._Sands
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - Other
profiles.icahn.mssm.edu/bruce-e-sands
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
Editorial & leadership roles
journal and society appointments- Chair of Immunology
Microbiology and Inflammatory Bowel Disease Section, American Gastroenterological Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗ - Chair of Clinical Research Alliance
Crohn's & Colitis Foundation of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗ - Past Chair
International Organization for the Study of Inflammatory Bowel Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.icahn.mssm.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗
- Jacobi Medallion from Mount Sinai
the institution's highest award
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →beckersasc.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Donna Mancini, MD
Icahn School of Medicine at Mount Sinai
Charles Rice, MD
The Rockefeller University
Naga Chalasani, MD
Indiana University School of Medicine
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute